litlas
ログインアカウント作成

David L. DeMets

1972–2025 年に発表

別表記
David L DeMets
94
論文数
53,350
被引用数
76
h 指数
91
i10 指数

被引用数

David L. DeMets の年別被引用数1970 年: 被引用 1 件1971 年: 被引用 1 件1976 年: 被引用 1 件1977 年: 被引用 6 件1978 年: 被引用 2 件1979 年: 被引用 6 件1980 年: 被引用 4 件1981 年: 被引用 7 件1982 年: 被引用 7 件1983 年: 被引用 9 件1984 年: 被引用 20 件1985 年: 被引用 13 件1986 年: 被引用 23 件1987 年: 被引用 17 件1988 年: 被引用 24 件1989 年: 被引用 30 件1990 年: 被引用 26 件1991 年: 被引用 41 件1992 年: 被引用 37 件1993 年: 被引用 60 件1994 年: 被引用 70 件1995 年: 被引用 77 件1996 年: 被引用 63 件1997 年: 被引用 87 件1998 年: 被引用 136 件1999 年: 被引用 124 件2000 年: 被引用 126 件2001 年: 被引用 138 件2002 年: 被引用 198 件2003 年: 被引用 199 件2004 年: 被引用 198 件2005 年: 被引用 278 件2006 年: 被引用 272 件2007 年: 被引用 242 件2008 年: 被引用 230 件2009 年: 被引用 251 件2010 年: 被引用 238 件2011 年: 被引用 193 件2012 年: 被引用 235 件2013 年: 被引用 242 件2014 年: 被引用 253 件2015 年: 被引用 254 件2016 年: 被引用 237 件2017 年: 被引用 259 件2018 年: 被引用 214 件2019 年: 被引用 904 件2020 年: 被引用 1,347 件2021 年: 被引用 1,433 件2022 年: 被引用 1,248 件2023 年: 被引用 1,087 件2024 年: 被引用 1,724 件2025 年: 被引用 897 件2026 年: 被引用 34 件1972〜1975 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,633 件、この内訳の 23.1%イギリス: 引用元論文 2,227 件、この内訳の 9.1%カナダ: 引用元論文 1,317 件、この内訳の 5.4%イタリア: 引用元論文 1,288 件、この内訳の 5.3%ドイツ: 引用元論文 1,218 件、この内訳の 5%中国: 引用元論文 923 件、この内訳の 3.8%オランダ: 引用元論文 908 件、この内訳の 3.7%フランス: 引用元論文 835 件、この内訳の 3.4%オーストラリア: 引用元論文 731 件、この内訳の 3%スウェーデン: 引用元論文 679 件、この内訳の 2.8%日本: 引用元論文 632 件、この内訳の 2.6%デンマーク: 引用元論文 620 件、この内訳の 2.6%
0%23.1%その他 30.2%

機関

分野

  • Medicine82.9%
  • Biochemistry, Genetics and Molecular Biology6.6%
  • Mathematics2.2%
  • Neuroscience1.1%
  • Economics, Econometrics and Finance0.9%
  • Immunology and Microbiology0.8%
  • その他5.5%

トピック

  • Diabetes Treatment and Management8.3%
  • Heart Failure Treatment and Management7.3%
  • Cardiovascular Function and Risk Factors5.7%
  • Cardiac pacing and defibrillation studies3.9%
  • Pancreatic function and diabetes2.1%
  • Cardiac electrophysiology and arrhythmias1.9%
  • その他70.8%

共著者

全論文

検索で開く
  1. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    著者: John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Inder S. Anand, Jan Bělohlávek, Michael Böhm, Chern‐En Chiang, Vijay Chopra, Rudolf A. de Boer, Akshay S. Desai, Mirta Díez, Jarosław Dróżdż, Andrej Dukát, Junbo Ge, Jonathan G. Howlett, Tzvetana Katova, Masafumi Kitakaze, Charlotta Ljungman, Béla Merkely, José Carlos Nicolau, Eileen O’Meara, Mark C. Petrie, Pham Nguyễn Vinh, Morten Schou, С. Н. Терещенко, Subodh Verma, Claes Held, David L. DeMets, Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson, Mikaela Sjöstrand, Anna-Maria Langkilde - New England Journal of Medicine 2019 被引用: 6,873

  2. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    著者: Scott D. Solomon, John J.V. McMurray, Brian Claggett, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Akshay S. Desai, Pardeep S. Jhund, Jan Bělohlávek, Chern‐En Chiang, C. Jan Willem Borleffs, Josep Comín‐Colet, Dan Dobreanu, Jarosław Dróżdż, James C. Fang, Marco A. Alcocer‐Gamba, Waleed Al Habeeb, Yaling Han, Jose Walter Cabrera Honorio, Stefan Janssens, Tzvetana Katova, Masafumi Kitakaze, Béla Merkely, Eileen O’Meara, José Francisco Kerr Saraiva, С. Н. Терещенко, Jorge Thierer, Muthiah Vaduganathan, Orly Vardeny, Subodh Verma, Vinh Pham, Ulrica Wilderäng, Natalia Zaozerska, Erasmus Bachus, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde - New England Journal of Medicine 2022 被引用: 2,658

  3. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    著者: Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, Ralph B. D’Agostino, Christopher B. Granger, Nigel C. Jones, Lawrence A. Leiter, Anne E Rosenberg, Kristina N. Sigmon, Matthew C. Somerville, Karl M. Thorpe, John J.V. McMurray, Stefano Del Prato, Stefano Del Prato, John J.V. McMurray, Ralph B. D’Agostino, Christopher B. Granger, Adrian F. Hernandez, Salim Janmohamed, Lawrence A. Leiter, Robert M. Califf, Rury R. Holman, David L. DeMets, Matthew C. Riddle, Shaun G. Goodman, Darren K. McGuire, Karen Alexander, Adam D. DeVore, Chiara Melloni, Chetan B. Patel, David C. M. Kong, Gerald S. Bloomfield, Matthew T. Roe, Pierluigi Tricoci, Robert W. Harrison, Renato D. Lópes, Robin Mathews, Rajendra Mehta, W. Schuyler Jones, Sreekanth Vemulapalli, Thomas J. Povsic, Zubin J. Eapen, Keith Dombrowski, Brad J. Kolls, J. Dedrick Jordan, Andrew P. Ambrosy, Stephen J. Greene, Aditya Mandawat, Jay Shavadia, Lauren B. Cooper, Abhinav Sharma, Patrícia O. Guimarães, Daniel J. Friedman, Matthew E. Wilson, Patricia Endsley, Tracy Gentry, Jeannie Collier, Kathleen Perez, K.E. James, Jennifer Roush, C. ARDEN III POPE, Christina Howell, Megan Johnson, M. Bailey, Joanna Cole, Teresa Akers, Beth Vandyne, Betsy Thomas, Jenny Rich, Susan Bartone, Gail Beaulieu, Kim Brown, Tuan Chau, Tamra Christian, Rebecca Coker, Deb Greene, Trevorlyn Haddock, Wendy Jenkins, Ghazala Haque, Marsha L. Marquess, Jean Pesarchick, Renee Rethaford, Allegra Stone, Firas Al- Kawas, Michelle A. Anderson, Robert Enns, Isaac Sinay, Chantal Mathieu, Victor Yordanov, Irene Hramiak, Martin Haluzı́k, Søren Galatius, Bruno Guerci, Michael A. Nauck, Ilias Migdalis, Choon Beng Kathryn Tan, Győző Kocsis, Andrea Giaccari, Moon Kyu Lee, Ernesto Muñoz ほか 708 名 - The Lancet 2018 被引用: 1,791

  4. Interpretation of the evidence for the efficacy and safety of statin therapy

    著者: Rory Collins, Christina Reith, Jonathan Emberson, Jane Armitage, Colin Baigent, Lisa Blackwell, Roger S. Blumenthal, John Danesh, George Davey Smith, David L. DeMets, Stephen Evans, Malcolm Law, Stephen MacMahon, Seth S. Martin, Bruce Neal, Neil R Poulter, David Preiss, Paul M. Ridker, Ian Roberts, Anthony Rodgers, Peter Sandercock, Kenneth F. Schulz, Peter Sever, John Simes, Liam Smeeth, Nicholas Wald, Salim Yusuf, Richard Peto - The Lancet 2016 被引用: 1,844

  5. Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER

    著者: Pardeep S. Jhund, Toru Kondo, Jawad H. Butt, Kieran F. Docherty, Brian Claggett, Akshay S. Desai, Muthiah Vaduganathan, Samvel B. Gasparyan, Olof Bengtsson, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Lars Køber, Carolyn S.P. Lam, Felipe A. Martínez, Marc S. Sabatine, Sanjiv J. Shah, Scott D. Solomon, John J.V. McMurray - Nature Medicine 2022 被引用: 275

  6. Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure

    著者: Michael R. Bristow, Leslie A. Saxon, John Boehmer, Steven K. Krueger, David A. Kass, Teresa De Marco, Peter E. Carson, Lorenzo A. DiCarlo, David L. DeMets, Bill G. White, Dale W. DeVries, Arthur M. Feldman - New England Journal of Medicine 2004 被引用: 5,817

  7. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure

    著者: Milton Packer, Michael B. Fowler, Ellen B. Roecker, Andrew J.S. Coats, Hugo A. Katus, Henry Krum, Paul Mohaçsi, Jean L. Rouleau, Michał Tendera, C Staiger, Terry L. Holcslaw, Ildikó Amann-Zalán, David L. DeMets - Circulation 2002 被引用: 1,346

  8. A Trial to Evaluate the Effect of the Sodium–Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Morbidity and Mortality in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA-HF)

    著者: John J.V. McMurray, David L. DeMets, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Anna Maria Langkilde, Felipe A. Martínez, Olof Bengtsson, Piotr Ponikowski, Marc S. Sabatine, Mikaela Sjöstrand, Scott D. Solomon - European Journal of Heart Failure 2019 被引用: 447

  9. Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial

    著者: Scott D. Solomon, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Daniel Lindholm, Ulrica Wilderäng, Fredrik Öhrn, Brian Claggett, Anna Maria Langkilde, Magnus Petersson, John J.V. McMurray - European Journal of Heart Failure 2021 被引用: 322

  10. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

    著者: Karen A. Hicks, Kenneth W. Mahaffey, Roxana Mehran, Steven E. Nissen, Stephen D. Wiviott, Billy Dunn, Scott D. Solomon, John R. Marler, John R. Teerlink, Andrew Farb, David A. Morrow, Shari Targum, Cathy A. Sila, Mary Thanh Hai, Michael R. Jaff, Hylton V. Joffe, Donald E. Cutlip, Akshay S. Desai, Eldrin F. Lewis, C. Michael Gibson, Martin Landray, A. Michael Lincoff, Christopher J. White, Steven S. Brooks, Kenneth Rosenfield, Michaël Domanski, Alexandra J. Lansky, John J.V. McMurray, James E. Tcheng, Steven R. Steinhubl, Paul Burton, Laura Mauri, Christopher M. O’Connor, Marc A. Pfeffer, Hung Hung, Norman Stockbridge, Bernard Chaitman, Robert J. Temple, Heather D. Fitter, Kachikwu Illoh, Kenneth J. Cavanaugh, Benjamin M. Scirica, Ilan Irony, Rachel E. Brown Kichline, Jonathan G. Levine, Anna Park, Leonard Sacks, Ana Szarfman, Ellis F. Unger, Lori Ann Wachter, Bram Zuckerman, Yale Mitchel, Douglas Peddicord, Thomas Shook, Bron Kisler, Charles L. Jaffe, Rhonda Bartley, David L. DeMets, MariJo Mencini, Cheri Janning, Steve Bai, John Lawrence, Ralph B. D’Agostino, Stuart Pocock - Journal of the American College of Cardiology 2018 被引用: 322

  11. Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction

    著者: Mikhail Kosiborod, Pardeep S. Jhund, Kieran F. Docherty, Mirta Díez, Mark C. Petrie, Subodh Verma, José Carlos Nicolau, Béla Merkely, Masafumi Kitakaze, David L. DeMets, Silvio E. Inzucchi, Lars Køber, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Scott D. Solomon, Olof Bengtsson, Daniel Lindholm, Anna Niklasson, Mikaela Sjöstrand, Anna Maria Langkilde, John J.V. McMurray - Circulation 2019 被引用: 345

  12. Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction

    著者: Scott D. Solomon, Muthiah Vaduganathan, Brian Claggett, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Jan Bělohlávek, Chern‐En Chiang, C. Jan Willem Borleffs, Josep Comín‐Colet, Dan Dobreanu, Jarosław Dróżdż, James C. Fang, Marco Antonio Alcocer Gamba, Waleed Al Habeeb, Yaling Han, Jose Walter Cabrera Honorio, Stefan Janssens, Tsvetana Katova, Masafumi Kitakaze, Béla Merkely, Eileen O’Meara, José Francisco Kerr Saraiva, Sergey Tereschenko, Jorge Thierer, Orly Vardeny, Subodh Verma, Pham Nguyễn Vinh, Ulrica Wilderäng, Natalia Zaozerska, Daniel Lindholm, Magnus Petersson, John J.V. McMurray - JACC Heart Failure 2022 被引用: 165

  13. Fundamentals of Clinical Trials

    著者: Lawrence M. Friedman, Curt D. Furberg, David L. DeMets, David M. Reboussin, Christopher B. Granger - 2015 被引用: 2,240

  14. Effect of Carvedilol on Survival in Severe Chronic Heart Failure

    著者: Milton Packer, Andrew J.S. Coats, Michael B. Fowler, Hugo A. Katus, Henry Krum, Paul Mohaçsi, Jean L. Rouleau, Michał Tendera, A Castaigne, Ellen B. Roecker, M. Schultz, C Staiger, E. Curtin, David L. DeMets - New England Journal of Medicine 2001 被引用: 3,096

  15. Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial

    著者: Alexander Peikert, Felipe A. Martínez, Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Sanjiv J. Shah, Tsvetana Katova, Béla Merkely, Orly Vardeny, Ulrica Wilderäng, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon - Circulation Heart Failure 2022 被引用: 124

  16. Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure

    著者: Milton Packer, Joseph R. Carver, Richard J. Rodeheffer, Russell J. Ivanhoe, Robert DiBianco, Steven M. Zeldis, G Hendrix, William J. Bommer, Uri Elkayam, Marrick Kukin, George I. Mallis, Josephine A. Sollano, James S. Shannon, Parul Tandon, David L. DeMets - New England Journal of Medicine 1991 被引用: 2,232

  17. Surrogate End Points in Clinical Trials: Are We Being Misled?

    著者: Thomas R. Fleming, David L. DeMets - Annals of Internal Medicine 1996 被引用: 1,633

  18. Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

    著者: Orly Vardeny, James C. Fang, Akshay S. Desai, Pardeep S. Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A. de Boer, Adrian F. Hernandez, Carolyn S.P. Lam, Silvio E. Inzucchi, Felipe A. Martínez, Mikhail Kosiborod, David L. DeMets, Eileen O’Meara, Shelley Zieroth, Josep Comín‐Colet, Jarosław Dróżdż, Chern‐En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon - Nature Medicine 2022 被引用: 67

  19. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age

    著者: Felipe A. Martínez, Matteo Serenelli, José Carlos Nicolau, Mark C. Petrie, Chern‐En Chiang, С. Н. Терещенко, Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Piotr Ponikowski, Marc S. Sabatine, David L. DeMets, Monika Dutkiewicz-Piasecka, Olof Bengtsson, Mikaela Sjöstrand, Anna Maria Langkilde, Pardeep S. Jhund, John J.V. McMurray - Circulation 2019 被引用: 207

  20. Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction

    著者: Jonathan W. Cunningham, Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Martina M. McGrath, Eileen O’Meara, Ulrica Wilderäng, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon - Journal of the American College of Cardiology 2022 被引用: 91

  21. Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease

    著者: Orly Vardeny, KyungMann Kim, Jacob A. Udell, Jacob Joseph, Akshay S. Desai, Michael E. Farkouh, Sheila M. Hegde, Adrian F. Hernandez, Allison McGeer, H. Keipp Talbot, Inder S. Anand, Deepak L. Bhatt, Christopher P. Cannon, David L. DeMets, J. Michael Gaziano, Shaun G. Goodman, Kristin L. Nichol, Matthew C. Tattersall, Jonathan L. Temte, Janet Wittes, Clyde W. Yancy, Brian Claggett, Yi Chen, Lu Mao, Thomas C. Havighurst, Lawton S. Cooper, Scott D. Solomon - JAMA 2020 被引用: 129

  22. Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF

    著者: Alice M. Jackson, Pooja Dewan, Inder S. Anand, Jan Bělohlávek, Olof Bengtsson, Rudolf A. de Boer, Michael Böhm, David W. Boulton, Vijay Chopra, David L. DeMets, Kieran F. Docherty, Andrej Dukát, Peter J. Greasley, Jonathan G. Howlett, Silvio E. Inzucchi, Tzvetana Katova, Lars Køber, Mikhail Kosiborod, Anna Maria Langkilde, Daniel Lindholm, Charlotta Ljungman, Felipe A. Martínez, Eileen O’Meara, Marc S. Sabatine, Mikaela Sjöstrand, Scott D. Solomon, С. Н. Терещенко, Subodh Verma, Pardeep S. Jhund, John J.V. McMurray - Circulation 2020 被引用: 174

  23. Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials

    著者: Peter Rossing, Silvio E Inzucchi, Priya Vart, Niels Jongs, Kieran F Docherty, Pardeep S Jhund, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Scott D Solomon, David L DeMets, Olof Bengtsson, Magnus Lindberg, Anna Maria Langkilde, Mikaela Sjöstrand, Bergur V Stefansson, Cecilia Karlsson, Glenn M Chertow, Fan Fan Hou, Ricardo Correa-Rotter, Robert D Toto, David C Wheeler, John J V McMurray, Hiddo J L Heerspink - The Lancet Diabetes & Endocrinology 2021 被引用: 73

  24. Methods for combining randomized clinical trials: Strengths and limitations

    著者: David L. DeMets - Statistics in Medicine 1987 被引用: 1,053